Jupiter Neurosciences has dosed the first patient

Cerevance announced positive topline results from

AgelessRx has launched GHK-Cu Cream, a prescripti

First-in-human ER-100 data support dose escalati

HepaRegeniX’s darizmetinib clears milestone in

Novartis’ President of Biomedical Research, Fi

Promis Neurosciences appointed Ivana Rubino, Ph.

Shift published research in Nature Biotechnology

Maze Therapeutics will present data for its lead

A peer-reviewed preclinical study published in Ex

Bexorg was awarded up to $28.

Researchers say women in Bolotana are reaching 1

As health data multiplies, Longevitix is buildin

At LIC 2026, investors, scientists and founders

Designerly’s Cooper Adwin looks at why generat

The company says its four-year lifespan screen f

New Singapore masterclass will give senior leade

A five-year NIA grant puts UCLA Health in charge

Chinese biotechs can run trials 50–70% faster

San Mateo-based Cala has launched nationwide avai

Resolution Therapeutics announced that interim da

Circular Genomics and Altoida are combining a bl

Mito now offers a coronary artery calcium scan w

The Miami longevity startup says it hopes to rea

AbbVie’s JUVMO (tavapadon) targets dopamine di

Six of ten patients in a small trial improved by

Alector has granted Genentech exclusive worldwide

Coya Therapeutics has completed enrollment of the

Alterity presented additional analyses of its ATH

Genflow Biosciences presented interim results fro

Deerfield’s Jim Flynn on shrinking error bars,

Annovis Bio is using an AI tool to speed up its

Aged beagle data hint at lower biological age an

ARDD moved from Copenhagen to Boston out of nece

As peptides surge in popularity, better evidence

Two Lilly candidates posted fresh data in type 2

BodySpec opened a storefront in downtown Oakland,

Atrogi announced positive human data for ATR-258

Digbi Health expanded its Precision Biology teleh

Supernal’s AI-assisted science-fiction trailer,

Surrozen announced that its investigational new d

Pharma has the podium as Novo and Lilly stop tal

Ten innovations spanning diagnostics, AI, mobili

A Tokyo startup called TIME TRAVELER thinks the

Zsolt Farkas of Evolut on why today’s longevit

The AI drug developer nominated ISM1354 for obes

VectorY Therapeutics expanded its Phase 1/2 PIONE

Better U and Evernow announced a strategic telehe

Kailera Therapeutics announced completion of enro

Longeveron will take part in three longevity and